Moneycontrol PRO
Loans
HomeNewsAsterdmhealthcareltd
Jump to
  • Buy Aster DM Healthcare; target of Rs 700: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 700: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 700 in its research report dated July 31, 2025.

  • Buy Aster DM Healthcare; target of Rs 620: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 620: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 620 in its research report dated May 22, 2025.

  • Buy Aster DM Healthcare; target of Rs 620 Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 620 Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 620 in its research report dated February 04, 2024.

  • Buy Aster DM Healthcare; target of Rs 620 Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 620 Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 620 in its research report dated December 02, 2024.

  • Buy Aster DM Healthcare; target of Rs 500 Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 500 Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 500 in its research report dated October 24, 2024.

  • Buy Aster DM Healthcare; target of Rs 400: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 400: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 400 in its research report dated August 01, 2024.

  • Buy Aster DM Healthcare; target of Rs 400: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 400: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 400 in its research report dated May 30, 2024.

  • Buy Aster DM Healthcare; target of Rs 515: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 515: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 515 in its research report dated April 02, 2024.

  • Buy Aster DM Healthcare; target of Rs 430: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 430: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 430 in its research report dated November 29, 2023.

  • Buy Aster DM Healthcare; target of Rs 345: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 345: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 345 in its research report dated August 16, 2023.

  • Buy Aster DM Healthcare; target of Rs 335: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 335: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 335 in its research report dated May 29, 2023.

  • Buy Aster DM Healthcare; target of Rs 265: Prabhudas Lilladher

    Buy Aster DM Healthcare; target of Rs 265: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 265 in its research report dated November 15, 2022.

  • Buy Aster DM Healthcare; target of Rs 250: ICICI Direct

    Buy Aster DM Healthcare; target of Rs 250: ICICI Direct

    ICICI Direct is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 250 in its research report dated August 12, 2022.

  • Buy Aster DM Healthcare; target of Rs 270: ICICI Direct

    Buy Aster DM Healthcare; target of Rs 270: ICICI Direct

    ICICI Direct is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 270 in its research report dated May 25, 2022.

  • Buy Aster DM Healthcare; target of Rs 250: ICICI Direct

    Buy Aster DM Healthcare; target of Rs 250: ICICI Direct

    ICICI Direct is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 250 in its research report dated February 10, 2021.

  • Buy Aster DM Healthcare; target of Rs 200: ICICI Direct

    Buy Aster DM Healthcare; target of Rs 200: ICICI Direct

    ICICI Direct is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 200 in its research report dated August 13, 2021.

  • Buy Aster DM Healthcare; target of Rs 210: ICICI Direct

    Buy Aster DM Healthcare; target of Rs 210: ICICI Direct

    ICICI Direct is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 210 in its research report dated February 10, 2021.

  • Buy Aster DM Healthcare target of Rs 155: ICICI Securities

    Buy Aster DM Healthcare target of Rs 155: ICICI Securities

    ICICI Securities is bullish on Aster DM Healthcare recommended buy rating on the stock with a target price of Rs 155 in its research report dated June 24, 2020.

  • Buy Aster DM Healthcare; target of Rs 224: Axis Capital

    Buy Aster DM Healthcare; target of Rs 224: Axis Capital

    Axis Capital is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 224 in its research report dated August 16, 2018.

  • Buy Aster DM Healthcare, target Rs 213: Goldman Sachs

    Buy Aster DM Healthcare, target Rs 213: Goldman Sachs

    Aster is likely to now enter a phase where it would have to sweat assets, improve cash flows and add leverage.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347